ID | 110709 |
著者 |
大塚, 秀樹
Division of Nuclear Medicine, Department of Radiology, University of Iowa|Department of Radiology, The University of Tokushima School of Medicine
徳島大学 教育研究者総覧
KAKEN研究者をさがす
Graham, Michael
Division of Nuclear Medicine, Department of Radiology, University of Iowa
久保, 亜貴子
Department of Radiology, The University of Tokushima School of Medicine
徳島大学 教育研究者総覧
KAKEN研究者をさがす
西谷, 弘
Department of Radiology, The University of Tokushima School of Medicine
徳島大学 教育研究者総覧
KAKEN研究者をさがす
|
キーワード | FDG PET
staging
restaging
therapy monitoring
head and neck cancer
|
資料タイプ |
学術雑誌論文
|
抄録 | The aim of this article is to introduce the clinical utility of FDG PET as oncologic imaging. PET (positron emission tomography) is a newly developed imaging tool, and it has increased the accuracy of metabolic mapping of numerous malignancies, with significant impact on the management of cancer patients for initial staging, restaging and therapy monitoring. PET can provide functional information in addition tomorphology from conventional imaging modalities. 18F-labeled 2-fluoro-2-deoxyglucose (FDG) is the most commonly used PET tracer and FDG PET can demonstrate the activity of glucose metabolism throughout the entire body in a single session. We describe the clinical utility of FDG in PET and display images of normal distribution and of patients with head and neck and lung cancer.
|
掲載誌名 |
The journal of medical investigation : JMI
|
ISSN | 13431420
|
cat書誌ID | AA11166929
|
巻 | 51
|
号 | 1-2
|
開始ページ | 14
|
終了ページ | 19
|
並び順 | 14
|
発行日 | 2004-02
|
EDB ID | |
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
医学系
病院
|